Tate S S, Galbraith R A
Department of Biochemistry, Cornell University Medical College, New York, N.Y.
Biochem Biophys Res Commun. 1988 Aug 15;154(3):1167-73. doi: 10.1016/0006-291x(88)90263-x.
Human hepatoma cell (Hep G2) gamma-glutamyl transpeptidase (gamma-GT), a 120 ka single-chain glycoprotein, is much larger than the expected precursor of the dimeric enzyme in other human tissues. However, the Hep G2 gamma-GT mRNA encodes a 63 kDa peptide, similar to that of rat gamma-GT mRNA product and to the predicted, unglycosylated precursor of the enzyme in human tissues. Translation in presence of dog pancreas microsomes results in processing of the 63 kDa to an 80 kDa core-glycosylated species which is subsequently cleaved to 58 and 22 kDa subunits resembling those in other human tissues. The unusually large Mr of gamma-GT in Hep G2 would thus seem to be due to further glycosylation and processing in the Golgi. A deficiency of the processing protease is the most likely reason for the persistence of the single-chain form of gamma-GT in Hep G2 cells.
人肝癌细胞(Hep G2)γ-谷氨酰转肽酶(γ-GT)是一种120 kDa的单链糖蛋白,比其他人体组织中预期的二聚体酶前体要大得多。然而,Hep G2 γ-GT mRNA编码一种63 kDa的肽,类似于大鼠γ-GT mRNA产物以及人体组织中该酶预测的未糖基化前体。在犬胰腺微粒体存在的情况下进行翻译,会将63 kDa的产物加工成80 kDa的核心糖基化物种,随后该物种会被切割成58 kDa和22 kDa的亚基,类似于其他人体组织中的亚基。因此,Hep G2中γ-GT异常大的分子量似乎是由于在高尔基体中进一步的糖基化和加工所致。加工蛋白酶的缺乏最有可能是γ-GT单链形式在Hep G2细胞中持续存在的原因。